Acute Worsening of Glycaemic Control in a Patient with Latent Autoimmune Diabetes of Adulthood After Receiving the COVID-19 Vaccine

Abstract

Patients with diabetes who are infected with severe acute respiratory syndrome coronavirus 2 experience a worsening of glycaemic control and are at increased risk for severe outcomes. Little is known regarding the impact of COVID-19 vaccinations on glycaemic control. This case report explores a patient with diabetes who experienced an acute worsening of glucose control in the week following the second dose of the Pfizer-BioNTech COVID-19 vaccine.